Teon Therapeutics Competitors and Similar CompaniesClear all
Teon Therapeutics's competitors and similar companies include ASLAN Pharmaceuticals and Agenus.
 Teon Therapeutics Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity. |  ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Founding Date | Founding Date 2017 | Founding Date N/A | Founding Date 1994 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Redwood City, US HQ | Locations SG HQ Collingwood, AU | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 6 | Employees 35 | Employees 8174% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $114.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $12m (FY, 2023) | Gross profit $113.2m (FY, 2025) |
Net income | Net income N/A | Net income ($44.2m) (FY, 2023) | Net income ($3.1m) (FY, 2025) |
Funding | |||
Latest funding round | Latest funding round $ 30m (over 5 years ago) | Latest funding round $ 23m (almost 10 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 30m | Total funding raised $ 100m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
ASLAN Pharmaceuticals
HQ
SG
Employees
35
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
View companyAgenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company